Mirabella Financial Services »

Ambrx Biopharma shares owned by Mirabella Financial Services

Quarter-by-quarter ownership of Ambrx Biopharma shares owned by Mirabella Financial Services from 13F filings

Historical chart of Mirabella Financial Services investment in Ambrx Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Ambrx Biopharma held by Mirabella Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ambrx Biopharma by Mirabella Financial Services

Quarter filed Position value Share count Share price at filing
2023-12-31 $143k 10k 14.24

More positions owned by Mirabella Financial Services

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Verizon Communications (VZ)
Ptc (PTC)
Omni (OMC)
Stryker Corporation (SYK)
Apple (AAPL)
Edison International (EIX)
Abbott Laboratories (ABT)
Thermo Fisher Scientific (TMO)
Cintas Corporation (CTAS)
First Tr Exchange-traded Dj Internt Idx (FDN)

View all positions for Mirabella Financial Services

Top funds holding Ambrx Biopharma

Darwin Global Management
Cormorant Asset Management
Paradigm Biocapital Advisors
D. E. Shaw & Co
Nextech Invest
Balyasny Asset Management
Citadel Advisors
Logos Global Management
VR Adviser
Vanguard Group
T. Rowe Price Associates
WuXi AppTec
Millennium Management
Goldman Sachs Group
Federated Investors

View all funds holding Ambrx Biopharma